Works matching IS 00221899 AND DT 2023 AND VI 288

Results: 8

Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial.

Published in:

Journal of Infectious Diseases, 2023, v. 288, p. S83, doi. 10.1093/infdis/jiad300

By:

Chew, Kara W;
Moser, Carlee;
Yeh, Eunice;
Wohl, David A;
Daar, Eric S;
Ritz, Justin;
Javan, Arzhang Cyrus;
Eron, Joseph J;
Currier, Judith S;
Smith, Davey M;
Hughes, Michael D;
Team, for the ACTIV-2/A5401 Study

Publication type:

Article

Association Between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death in Nonhospitalized Adults With Mild-to-Moderate COVID-19.

Published in:

Journal of Infectious Diseases, 2023, v. 288, p. S117, doi. 10.1093/infdis/jiad287

By:

Giganti, Mark J;
Chew, Kara W;
Eron, Joseph J;
Li, Jonathan Z;
Pinilla, Mauricio;
Moser, Carlee;
Javan, Arzhang Cyrus;
Fischer, William A;
Klekotka, Paul;
Margolis, David;
Wohl, David Alain;
Coombs, Robert W;
Daar, Eric S;
Smith, Davey M;
Currier, Judith S;
Hughes, Michael D;
Team, for the ACTIV-2/A5401 Study

Publication type:

Article

Long COVID After Bamlanivimab Treatment.

Published in:

Journal of Infectious Diseases, 2023, v. 288, p. S126, doi. 10.1093/infdis/jiad286

By:

Evering, Teresa H;
Moser, Carlee B;
Jilg, Nikolaus;
Yeh, Eunice;
Sanusi, Busola;
Wohl, David A;
Daar, Eric S;
Li, Jonathan Z;
Klekotka, Paul;
Javan, Arzhang Cyrus;
Eron, Joseph J;
Currier, Judith S;
Hughes, Michael D;
Smith, Davey M;
Chew, Kara W;
Team, for the ACTIV-2/A5401 Study

Publication type:

Article

Variant-Specific Viral Kinetics in Acute COVID-19.

Published in:

Journal of Infectious Diseases, 2023, v. 288, p. S136, doi. 10.1093/infdis/jiad314

By:

Ribeiro, Ruy M;
Choudhary, Manish C;
Deo, Rinki;
Giganti, Mark J;
Moser, Carlee;
Ritz, Justin;
Greninger, Alexander L;
Regan, James;
Flynn, James P;
Wohl, David A;
Currier, Judith S;
Eron, Joseph J;
Hughes, Michael D;
Smith, Davey M;
Chew, Kara W;
Daar, Eric S;
Perelson, Alan S;
Li, Jonathan Z;
Team, for the ACTIV-2/A5401 Study

Publication type:

Article

Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials.

Published in:

Journal of Infectious Diseases, 2023, v. 288, p. S101, doi. 10.1093/infdis/jiad285

By:

Moser, Carlee B;
Chew, Kara W;
Giganti, Mark J;
Li, Jonathan Z;
Aga, Evgenia;
Ritz, Justin;
Greninger, Alexander L;
Javan, Arzhang Cyrus;
Ignacio, Rachel Bender;
Daar, Eric S;
Wohl, David A;
Currier, Judith S;
Eron, Joseph J;
Smith, Davey M;
Hughes, Michael D;
Team, for the ACTIV-2/A5401 Study

Publication type:

Article

ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients.

Published in:

Journal of Infectious Diseases, 2023, v. 288, p. S77, doi. 10.1093/infdis/jiad246

By:

Currier, Judith S;
Moser, Carlee;
Eron, Joseph J;
Chew, Kara W;
Smith, Davey M;
Javan, Arzhang Cyrus;
Wohl, David Alain;
Daar, Eric S;
Hughes, Michael D;
Team, for the ACTIV-2/A5401 Study

Publication type:

Article

Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial.

Published in:

Journal of Infectious Diseases, 2023, v. 288, p. S92, doi. 10.1093/infdis/jiad209

By:

Moser, Carlee B;
Chew, Kara W;
Ritz, Justin;
Newell, Matthew;
Javan, Arzhang Cyrus;
Eron, Joseph J;
Daar, Eric S;
Wohl, David A;
Currier, Judith S;
Smith, Davey M;
Hughes, Michael D;
Team, for the ACTIV-2/A5401 Study

Publication type:

Article

Immune Status and SARS-CoV-2 Viral Dynamics.

Published in:

Journal of Infectious Diseases, 2023, v. 288, p. S111, doi. 10.1093/infdis/jiad200

By:

Li, Yijia;
Moser, Carlee;
Aga, Evgenia;
Currier, Judith S;
Wohl, David A;
Daar, Eric S;
Ritz, Justin;
Greninger, Alexander L;
Sieg, Scott;
Parikh, Urvi M;
Coombs, Robert W;
Hughes, Michael D;
Eron, Joseph J;
Smith, Davey M;
Chew, Kara W;
Li, Jonathan Z;
Team, for the ACTIV-2/A5401 Study

Publication type:

Article